C9 - complement C9 Gene
Species: Canis lupus familiaris (sub-species: familiaris)
Gene Type: protein coding
Gene ID: 479354
C9 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_038663872.1 | XP_038519800.1 | complement component C9 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
complement component C9 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(16)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-17356 | Fenofibrate | 99.97% | Yes | |
| HY-B0113 | Omeprazole | Inhibitor | 99.96% | Yes |
| HY-N6972 | Cepharanthine | 99.87% | Yes | |
| HY-B1218 | Sulfaphenazole | Inhibitor | 99.85% | Unkown |
| HY-B0258 | Gemfibrozil | 99.91% | Yes | |
| HY-11103 | Sitaxsentan sodium | 98.83% | Unkown | |
| HY-100386 | Ticlopidine | Inhibitor | 99.74% | Unkown |
| HY-B0113A | Omeprazole sodium | Inhibitor | 99.10% | Yes |
| HY-13463 | Avatrombopag | Agonist | 99.83% | Yes |
| HY-B0153A | Ticlopidine hydrochloride | Inhibitor | 99.99% | Unkown |
| HY-13463A | Avatrombopag maleate | 99.99% | Yes | |
| HY-B0113R | Omeprazole (Standard) | Inhibitor | 99.86% | Unkown |
| HY-13463B | Avatrombopag hydrochloride | Agonist | 97.05% | Yes |
| HY-76520 | Sitaxsentan | / | Unkown | |
| HY-109546 | Omeprazole magnesium | Inhibitor | / | Unkown |
| HY-111654 | Diflucortolone | / | Unkown |
Clinical Phase
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-132581 | Tadnersen | Inhibitor | 99.30% | Phase 3 |
| HY-121872 | DP-b99 | Inhibitor | 95.0% | Phase 3 |
| HY-N1201 | Apigenin | 99.22% | Phase 2 | |
| HY-106379 | Lurosetron | Antagonist | / | Phase 2 |
| HY-19397 | BMS-223131 | / | Phase 2 | |
| HY-15565 | APD668 | 99.73% | Phase 1 | |
| HY-132581A | Tadnersen sodium | Inhibitor | 99.30% | Phase 1 |
| HY-15566 | APD597 | Agonist | 99.97% | Phase 1 |
| HY-12946 | BI 653048 | Inhibitor | 99.84% | Phase 1 |
| HY-114415 | AWZ1066S | Inhibitor | 98.64% | Phase 1 |
| HY-12946A | BI 653048 phosphate | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(234)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N0904 | Ginsenoside C-K | Inhibitor | 99.93% | Unkown |
| HY-N0893 | Tetrahydrocurcumin | 98.96% | Unkown | |
| HY-15550 | 4'-Hydroxy diclofenac | 99.70% | Unkown | |
| HY-N0043 | Ginsenoside Rd | Inhibitor | 99.88% | Unkown |
| HY-15550S | 4'-Hydroxy diclofenac-d4 | 98.92% | Unkown | |
| HY-W013268 | (S)-(+)-N-3-Benzylnirvanol | Inhibitor | 99.76% | Unkown |
| HY-103661 | BI-6C9 | Inhibitor | 98.47% | Unkown |
| HY-N0762 | Isobavachin | 99.88% | Unkown | |
| HY-N1446S | Oleic acid-13C | 99.99% | Unkown | |
| HY-D1422 | ER Tracker Yellow | 96.91% | Unkown | |
| HY-114759 | MS-PPOH | Inhibitor | 99.05% | Unkown |
| HY-117026 | LKY-047 | Inhibitor | 99.94% | Unkown |
| HY-153898 | rTRD01 | Ligand | 99.10% | Unkown |
| HY-100738 | Ubiquitin Isopeptidase Inhibitor I, G5 | Inducer | 98.0% | Unkown |
| HY-N0473S3 | L-Tyrosine-13C9 | 99.81% | Unkown | |
| HY-N0215S10 | L-Phenylalanine-13C9 | Antagonist | 98.09% | Unkown |
| HY-100641 | 4-Hydroxytolbutamide | 99.69% | Unkown | |
| HY-N1201R | Apigenin (Standard) | 98.82% | Unkown | |
| HY-170538 | SNT-5382 | Inhibitor | 99.96% | Unkown |
| HY-18063 | ML252 | Inhibitor | 99.9% | Unkown |
| HY-117389 | Homocarbonyltopsentin | 99.82% | Unkown | |
| HY-W140827 | Boc-C9-Br | / | Unkown | |
| HY-N0215S11 | L-Phenylalanine-13C9,15N | Antagonist | 99.42% | Unkown |
| HY-N0920 | Dihydrokavain | Inhibitor | 99.94% | Unkown |
| HY-B0158S7 | Cytidine-13C9 | Chemical | 98.69% | Unkown |
| HY-N0688 | Linderane | Inhibitor | 98.61% | Unkown |
| HY-W013175S2 | Uridine 5'-monophosphate-13C9,15N2 disodium | Activator | 99.77% | Unkown |
| HY-139345 | (S,R,S)-AHPC-CO-C9-acid | Chemical | 95.00% | Unkown |
| HY-N1050 | Zederone | Inhibitor | 99.61% | Unkown |
| HY-100641S | 4-Hydroxytolbutamide-d9 | 99.29% | Unkown | |
| HY-42034 | Hydroquinine | 99.87% | Unkown | |
| HY-W751165 | Uridine-13C9,15N2 | 98.88% | Unkown | |
| HY-113359AS2 | Uridine 5'-diphosphate-13C9,15N2 dilithium | Agonist | 99.15% | Unkown |
| HY-125818S3 | Cytidine-5'-triphosphate-13C9 dilithium | 98.02% | Unkown | |
| HY-14362 | GSK-25 | Inhibitor | 98.33% | Unkown |
| HY-148822 | Nampt activator-2 | Activator | 98.79% | Unkown |
| HY-N0911 | Rehmannioside A | 99.95% | Unkown | |
| HY-W108995 | Boc-C9-COOH | ≥97.0% | Unkown | |
| HY-128859 | EMT inhibitor-2 | Inhibitor | 98.83% | Unkown |
| HY-B1449S11 | Uridine-13C9 | 96.8% | Unkown | |
| HY-116862 | Dibenzylfluorescein | 99.54% | Unkown | |
| HY-B0113S | Omeprazole-d3 | Inhibitor | 98.99% | Unkown |
| HY-147294 | Nivasorexant | 99.74% | Unkown | |
| HY-144652 | IDO1-IN-19 | Inhibitor | 98.82% | Unkown |
| HY-17356R | Fenofibrate (Standard) | 99.92% | Unkown | |
| HY-B0258R | Gemfibrozil (Standard) | 99.82% | Unkown | |
| HY-N7057S3 | Nonanoic acid-d2 | 98.0% | Unkown | |
| HY-W009162S5 | Cytidine 5′-monophosphate-13C9,15N3 dilithium | 99.80% | Unkown | |
| HY-N11222 | Nonanoylcarnitine | 99.87% | Unkown | |
| HY-W587878 | Thujopsene | 86.31% | Unkown | |
| HY-17356S | Fenofibrate-d6 | 99.70% | Unkown | |
| HY-B0113S3 | Omeprazole-13C,d3 | Inhibitor | 98.00% | Unkown |
| HY-N1201S | Apigenin-d5 | 98.90% | Unkown | |
| HY-N5132 | (-)-Fenchone | 98.0% | Unkown | |
| HY-Y0123S | L-Tyrosine-13C9,15N | 98.0% | Unkown | |
| HY-107372S2 | Uridine triphosphate-13C9 dilithium | 99.33% | Unkown | |
| HY-161943 | NEU3-IN-1 | 98.74% | Unkown | |
| HY-170510 | GB2095 | Inhibitor | 98.92% | Unkown |
| HY-D0184S3 | 2'-Deoxycytidine-13C9,15N3 | 98.74% | Unkown | |
| HY-N8382 | Chalepensin | Inhibitor | 98.98% | Unkown |
| HY-15550S1 | 4'-Hydroxy diclofenac-13C6 | 99.21% | Unkown | |
| HY-W018801 | 5-Nitroisoquinoline | 99.38% | Unkown | |
| HY-A0070AS1 | Liothyronine-13C9,15N | / | Unkown | |
| HY-W009216S1 | 2'-Deoxycytidine-5'-monophosphate-13C9,15N3 dilithium | 99.8% | Unkown | |
| HY-B0258S | Gemfibrozil-d6 | 98.71% | Unkown | |
| HY-101399S | γ-Glu-(Phe-13C9,15N) | / | Unkown | |
| HY-107372S | Uridine triphosphate-13C9,15N2 sodium | / | Unkown | |
| HY-124352 | 2-Nonyl-3-hydroxy-4-quinolone | 98.0% | Unkown | |
| HY-131495 | (S)-6-O-Desmethylnaproxen | Inhibitor | 95.73% | Unkown |
| HY-138527 | Thiol-C9-PEG4 | 99.06% | Unkown | |
| HY-155265 | Pomalidomide-5-C9-NH2 hydrochloride | 98.68% | Unkown | |
| HY-156159 | Thalidomide-NH-C9-NH2 hydrochloride | Inducer | 99.85% | Unkown |
| HY-U00048 | Bucolome | Inhibitor | 98.93% | Unkown |
| HY-W141374 | CB096 | 98.72% | Unkown | |
| HY-Z2667 | (R)-Esomeprazole | Modulator | 96.41% | Unkown |
| HY-101399SA | γ-Glu-(Phe-13C9,15N) TFA | 99.74% | Unkown | |
| HY-117160 | 4-trans-Hydroxy-glibenclamide | Inhibitor | 99.0% | Unkown |
| HY-132581E | Scrambled Tadnersen | Control | / | Unkown |
| HY-159191S | VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI TFA | 95.41% | Unkown | |
| HY-18063A | ML252 hydrochloride | Inhibitor | 98.5% | Unkown |
| HY-B0158S5 | Cytidine-13C9,15N3 | 98.9% | Unkown | |
| HY-N6023 | Thermopsoside | 98.0% | Unkown | |
| HY-172177 | ROCK/HDAC-IN-2 | / | Unkown | |
| HY-135390 | Hydroxy desmethyl Bosentan | / | Unkown | |
| HY-100386S | Ticlopidine-d4 | Inhibitor | / | Unkown |
| HY-100641S1 | 4-Hydroxytolbutamide-d9-1 | / | Unkown | |
| HY-101400S2 | Deoxycytidine triphosphate-13C9,15N3 dilithium | Activator | / | Unkown |
| HY-101400S4 | Deoxycytidine triphosphate-13C9 dilithium | Activator | / | Unkown |
| HY-101981S3 | Uridine 5'-monophosphate-13C9,15N2 dilithium | Activator | / | Unkown |
| HY-101981S4 | Uridine 5'-monophosphate-13C9 dilithium | Activator | / | Unkown |
| HY-105408A | Fandosentan potassium | / | Unkown | |
| HY-10575 | MK-5596 | / | Unkown | |
| HY-111906 | SCYX-6759 | Inhibitor | / | Unkown |
| HY-113359AS1 | Uridine 5'-diphosphate-13C9 dilithium | Agonist | / | Unkown |
| HY-113400S1 | Cytidine diphosphate-13C9 dilithium | / | Unkown | |
| HY-113400S2 | Cytidine diphosphate-13C9,15N3 dilithium | 99.7% | Unkown | |
| HY-113887 | Prostaglandin F1β | Agonist | / | Unkown |
| HY-113887A | 11β-Prostaglandin F1β | Control | / | Unkown |
| HY-116095 | CypD-IN-5 | Inhibitor | / | Unkown |
| HY-116601 | 6-Hydroxywarfarin | 99.87% | Unkown | |
| HY-116811 | AZ-11665362 | / | Unkown | |
| HY-119781 | Kaitocephalin | Antagonist | / | Unkown |
| HY-119996 | AR-C141990 | Inhibitor | / | Unkown |
| HY-121698 | GW694481 | Inhibitor | / | Unkown |
| HY-122163 | MK-3901 | / | Unkown | |
| HY-132581C | Scrambled Tadnersen sodium | Control | / | Unkown |
| HY-13463BS | Avatrombopag-d8 hydrochloride | Agonist | / | Unkown |
| HY-138517 | Thiol-C9-PEG7 | / | Unkown | |
| HY-138526 | Thiol-C9-PEG4-acid | / | Unkown | |
| HY-138528 | Thiol-C9-PEG5-acid | / | Unkown | |
| HY-138529 | Thiol-C9-PEG5 | / | Unkown | |
| HY-138586S | DMT-dC(ac) Phosphoramidite-13C9, 15N3 | / | Unkown | |
| HY-141547 | Nav1.7-IN-8 | Inhibitor | / | Unkown |
| HY-141878 | di-Ellipticine-RIBOTAC | / | Unkown | |
| HY-141878A | di-Ellipticine-RIBOTAC TFA | / | Unkown | |
| HY-141913S | 3-Chlorotyrosine-13C9, 15N hydrochloride | / | Unkown | |
| HY-143906 | URAT1 inhibitor 2 | Inhibitor | / | Unkown |
| HY-145490 | trans-Hydroxy Glimepiride | / | Unkown | |
| HY-147807 | HIV-1 inhibitor-40 | Inhibitor | / | Unkown |
| HY-148597 | FGFR-IN-10 | Inhibitor | / | Unkown |
| HY-149566 | Thalidomide-5-O-C9-NH2 hydrochloride | Inducer | 99.59% | Unkown |
| HY-149572 | Thalidomide-4-O-C9-NH2 hydrochloride | Inducer | 99.26% | Unkown |
| HY-149866 | HIV-1 inhibitor-58 | Inhibitor | / | Unkown |
| HY-150710S | Cytidine 5'-triphosphate-13C9,15N3 ammonium | / | Unkown | |
| HY-151251 | CYP2C9/CYP2C19-IN-1 | Inhibitor | / | Unkown |
| HY-151253 | CYP2C1/CYP2C19-IN-2 | Inhibitor | / | Unkown |
| HY-153371 | 50-C2-C9-4tail | / | Unkown | |
| HY-153970 | URAT1 inhibitor 7 | Inhibitor | 98.01% | Unkown |
| HY-156133 | Dihydrospinosyn A aglycone | / | Unkown | |
| HY-159143 | BChE-IN-33 | Inhibitor | / | Unkown |
| HY-160555 | (S,R,S)-AHPC-CO-C9-NH2 | / | Unkown | |
| HY-160555A | (S,R,S)-AHPC-CO-C9-NH2 hydrochloride | 98.79% | Unkown | |
| HY-163208 | VH 032 amide-alkylC9-amine hydrochloride | / | Unkown | |
| HY-163816 | Antiproliferative agent-53-d3 | Inhibitor | / | Unkown |
| HY-164031A | Cloperidone hydrochloride | Inhibitor | / | Unkown |
| HY-164111 | JNK-IN-17 | Inhibitor | / | Unkown |
| HY-166530S | Ticlopidine-d6 hydrochloride | Inhibitor | / | Unkown |
| HY-166934S | Endosulfan-13C9 sulfate | / | Unkown | |
| HY-167872 | Bifeprofen | Inhibitor | / | Unkown |
| HY-168235 | (S,R,S)-AHPC-Me-amide-C9-acid | Degrader | / | Unkown |
| HY-168277 | 5-Aminothalidomide-C9-Boc | / | Unkown | |
| HY-169095 | (S,R,S)-AHPC-Me-CO-C9-NH2 | / | Unkown | |
| HY-171722 | Ascr#10 | Activator | / | Unkown |
| HY-171837 | c9,t11,c15-CLNA | Activator | / | Unkown |
| HY-172897 | EGFR/DHFR-IN-2 | / | Unkown | |
| HY-172902 | RNA binder 1 | / | Unkown | |
| HY-173032 | VU6033685 | Agonist | / | Unkown |
| HY-17356G | Fenofibrate (GMP) | / | Unkown | |
| HY-17356S1 | Fenofibrate-d4 | / | Unkown | |
| HY-175447 | GDC-0152-amide-PEG2-acid | / | Unkown | |
| HY-175887 | Pomalidomide-C9-Br | / | Unkown | |
| HY-175977 | BnO-CO-O-C9-O-COOH | / | Unkown | |
| HY-176737 | TGF-β1/Smad-IN-1 | Inhibitor | / | Unkown |
| HY-176905 | Tacedinaline-C9-acid | / | Unkown | |
| HY-177070 | Angexostat | Inhibitor | / | Unkown |
| HY-178479 | IDO1-IN-30 | / | Unkown | |
| HY-178786 | RET-IN-31 | Inhibitor | / | Unkown |
| HY-179154 | α-Glucosidase-IN-101 | Inhibitor | / | Unkown |
| HY-181321 | Thalidomide-4-O-C9-Br | / | Unkown | |
| HY-181611 | Polθ-IN-10 | / | Unkown | |
| HY-181662 | DLK-IN-2 | Inhibitor | / | Unkown |
| HY-181747 | CYP11A1-IN-3 | Inhibitor | / | Unkown |
| HY-182602 | KOSN 1724 | Inhibitor | / | Unkown |
| HY-182890 | Thalidomide-5-NH-C9-acid | / | Unkown | |
| HY-183017 | N-Descyclopropanecarbaldehyde olaparib-CO-C9-NHBoc | / | Unkown | |
| HY-18341S3 | L-Thyroxine-13C9,15N | / | Unkown | |
| HY-184233 | C9S | Degrader | / | Unkown |
| HY-79131S1 | Fmoc-Phe-OH-13C9,15N | 99.33% | Unkown | |
| HY-B0113S1 | Omeprazole-d3-1 | Inhibitor | 95.09% | Unkown |
| HY-B0153AS | Ticlopidine-d4 hydrochloride | Inhibitor | / | Unkown |
| HY-B1218S | Sulfaphenazole-d4 | 99.66% | Unkown | |
| HY-B1422S | 9-Aminoacridine-13C6 | Inhibitor | / | Unkown |
| HY-D0184S5 | 2'-Deoxycytidine-13C9 | 96.8% | Unkown | |
| HY-N0043R | Ginsenoside Rd (Standard) | Inhibitor | / | Unkown |
| HY-N0215S9 | L-Phenylalanine-13C9,15N,d8 | Antagonist | / | Unkown |
| HY-N0893S | Tetrahydrocurcumin-d6 | / | Unkown | |
| HY-N0904R | Ginsenoside C-K (Standard) | Inhibitor | / | Unkown |
| HY-N1201S1 | Apigenin-13C | / | Unkown | |
| HY-P0073S | Tyr-Gly-Gly-{Phe-13C9,15N}-Met-OH TFA | / | Unkown | |
| HY-P5538S | EPYFGYSGAFK-13C9,15N3 TFA | / | Unkown | |
| HY-RS00534 | AKR1C1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01759 | C9 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01760 | C9orf72 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01761 | C9orf78 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS03460 | CYP2C9 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W009216S4 | 2'-Deoxycytidine-5'-monophosphate-13C9 dilithium | 99.5% | Unkown | |
| HY-W011090S | ((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 sodium | / | Unkown | |
| HY-W015007S | Metyrosine-13C9,15N,d7 | Inhibitor | / | Unkown |
| HY-W018386AS | 3-Bromo-L-tyrosine-13C9,15N TFA | / | Unkown | |
| HY-W018386S1 | 3-Bromo-L-tyrosine-13C9 | / | Unkown | |
| HY-W042357S4 | Ac-rC Phosphoramidite-13C9 | / | Unkown | |
| HY-W042357S6 | Ac-rC Phosphoramidite-13C9,15N3 | / | Unkown | |
| HY-W048482S1 | rU Phosphoramidite-13C9,15N2 | / | Unkown | |
| HY-W048482S2 | rU Phosphoramidite-13C9 | / | Unkown | |
| HY-W127393 | N-Nonanoyl-L-homoserine lactone | / | Unkown | |
| HY-W140208 | 3-Phenylthiophene | Inhibitor | / | Unkown |
| HY-W663179 | DNDI-VL-2098 | Inhibitor | / | Unkown |
| HY-W707554 | Ticlopidine hydrochloride-d6 | / | Unkown | |
| HY-W753181 | (S)-2-Hydroxy-3-phenylpropanoic acid-13C9 | / | Unkown | |
| HY-117925 | Personalised postprandial-targeting | Inhibitor | / | Unkown |
| HY-124209 | 9-keto Fluprostenol | / | Unkown | |
| HY-124352S | 2-Nonyl-3-hydroxy-4-quinolone-d4 | / | Unkown | |
| HY-134999 | 10-Hydroxywarfarin | Inhibitor | / | Unkown |
| HY-150712S | Uridine triphosphate-13C9,15N2 dilithium | / | Unkown | |
| HY-164031 | Cloperidone | Inhibitor | / | Unkown |
| HY-169119 | Antifungal agent 114 | Inhibitor | / | Unkown |
| HY-169735 | Aurora A inhibitor 4 | Inhibitor | / | Unkown |
| HY-170367 | Antimicrobial agent-35 | Inhibitor | / | Unkown |
| HY-172335 | C9-200 | / | Unkown | |
| HY-17356S2 | Fenofibrate-13C6 | / | Unkown | |
| HY-175169 | Urease-IN-21 | Inhibitor | / | Unkown |
| HY-178479A | (Rac)-IDO1-IN-30 | / | Unkown | |
| HY-180227 | URAT1-IN-15 | Inhibitor | / | Unkown |
| HY-180273 | Antibacterial agent 309 | Inhibitor | / | Unkown |
| HY-182976 | Tenovin-3-CO-C9-NH2 | / | Unkown | |
| HY-76520S | Sitaxsentan-13C6 | / | Unkown | |
| HY-B0113S2 | Omeprazole sulfone (methoxy-d3) | Inhibitor | 99.70% | Unkown |
| HY-B0113S4 | Omeprazole-d3 sodium | Inhibitor | / | Unkown |
| HY-B0113S5 | Omeprazole-d6 | Inhibitor | / | Unkown |
| HY-B0258S1 | Gemfibrozil-d6-1 | / | Unkown | |
| HY-N12962 | 11S(12R)-EET | / | Unkown | |
| HY-N12962A | 11R(12S)-EET | / | Unkown | |
| HY-N7482 | Pyranocoumarin | / | Unkown | |
| HY-P0036S3 | Octreotide-13C9,15N | / | Unkown | |
| HY-RS17317 | C9 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20470 | Psma4 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21991 | C9orf72 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23772 | C9 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W008016S | Fmoc-Tyr(tBu)-OH-13C9,15N | 98.8% | Unkown | |
| HY-W009162S1 | Cytidine 5′-monophosphate-13C9 dilithium | / | Unkown | |
| HY-W413619 | Cipargamin enantiomer | Inhibitor | / | Unkown |
| HY-W440809 | Nonyl 8-bromooctanoate | / | Unkown | |
| HY-W800740 | Nonyl 6-bromohexanoate | / | Unkown | |
| HY-113623 | Pyrenophorol | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99141 | Anti-Mouse LAG-3 Antibody (C9B7W) | Inhibitor | 99% | Unkown |
| HY-P990140 | Anti-Rat β-2-Microglobulin Antibody (4C9) | / | Unkown | |
| HY-P990204 | Anti-Mouse LAG-3 (D265A) Antibody (C9B7W) | Inhibitor | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service